Business
IMC Announces Filing of Final Short Form Base Shelf Prospectus
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 31, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC)( NASDAQ:IMCC), a multi-country operator
About this update from Im Cannabis Corp.
[{"type":"text","content":"TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 31, 2021 / IM Cannabis Corp. (the \"Company\" or \"IMC\") (CSE:IMCC)( NASDAQ:IMCC), a multi-country operator (\"MCO\") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that it has filed a final short form base shelf prospectus (the \"Shelf Prospectus\") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada and a corresponding shelf registration statement on Form F-10 (the \"Registration Statement\") with the United States Securities and Exchange Commission (the \"SEC\") under the Multijurisdictional Disclosure System established between Canada and the United States.The Shelf Prospectus and Registration Statement, when declared effective, will allow the Company to offer up to an aggregate of US$250,000,000 (or its equivalent in other currencies) of common shares, warrants, subscription receipts, debt securities, units (collectively, the \"Securities\"), or any combination of such Securities from time to time, during the 25-month period that the Shelf Prospectus remains effective. The specific terms of any offering under the Shelf Prospectus and the intended use of the net proceeds will be established in a prospectus supplement (a \"Prospectus Supplement\"), which will be filed with the applicable Canadian securities regulatory authorities and the SEC in connection with any such offering. The Company may also use the Shelf Prospectus in connection with an \"at-the-market distribution\" (as defined in National Instrument 44-102 - Shelf Distributions) in accordance with applicable securities regulations, which would permit eligible Securities to be sold on behalf of the Company through the Canadian Securities Exchange (\"CSE\") or the NASDAQ Capital Market (\"NASDAQ\") as further described in the applicable prospectus supplement. Unless otherwise specified in a prospectus supplement, the Company may use the net proceeds from the sale of Securities for general corporate and working capital purposes, capital expenditures and future acquisitions, among other potential uses.This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these Securities in any jurisdiction in which such offer, soli...